1. Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, et al. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. Am Heart J 2006;52:863–866.
2. Saksena S, Madan N. Hybrid therapy of atrial fibrillation: algorithms and outcome. J Interv Cardid Electrophysiol 2003;9:235–247.
3. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:257–354.
4. Chen X. Clinical arrhythmology-electrophysiology and treatment. Beijing: People’s Medical Publishing House; 2000:780–789.
5. Cao KJ, Chen ML. Strengthen the comprehensive therapy of atrial fibrillation. Chin J Cardiol 2006;34:766–768.